Concepedia

David Song

DS

Statistics

Publications

49

Citations

3.8K

H-Index

31

Active since

1993

Affiliations

University of California San Diego(Current)

VA San Diego Healthcare System

Harvard University

Icahn School of Medicine at Mount Sinai

Rutgers, The State University of New Jersey

David Song is an author at University of California San Diego specializing in neuroscience, medicine, and neurology.

ORCID

Publications per year

1993–2023

49

Publications

49

Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promoters

Edward Rockenstein, Margaret Mallory, Makoto Hashimoto et al. · Journal of Neuroscience Research · 2002 · 509 citations

, , +16

A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease

M. Flint Beal, David Oakes, Ira Shoulson et al. · JAMA Neurology · 2014 · 395 citations · Full text

, , +17

Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP111-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

David Song, Clifford W. Shults, Abbyann Sisk et al. · Experimental Neurology · 2003 · 292 citations

, , +16

Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human α-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy

Clifford W. Shults, Edward Rockenstein, Leslie Crews et al. · Journal of Neuroscience · 2005 · 262 citations · Full text

, , +17

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease

Clifford W. Shults, M. Flint Beal, David Song et al. · Experimental Neurology · 2004 · 221 citations

, , +13

1–5 of 49